- Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
- Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
- Sensus Healthcare to Participate in the 36th Annual Roth Conference
- Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
- Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
- Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
- Sensus Healthcare Announces Retirement of Director Samuel O’Rear
- Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
- Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
- Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
More ▼
Key statistics
On Friday, Sensus Healthcare Inc (SRTS:NAQ) closed at 3.65, -32.16% below its 52-week high of 5.38, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.99 |
---|---|
High | 4.00 |
Low | 3.53 |
Bid | 3.62 |
Offer | 4.61 |
Previous close | 3.86 |
Average volume | 84.77k |
---|---|
Shares outstanding | 16.39m |
Free float | 12.89m |
P/E (TTM) | 125.21 |
Market cap | 59.84m USD |
EPS (TTM) | 0.0292 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼